To evaluate the cariogenic properties of almond milk beverages, 6 almond milks, along with soy and whole bovine milk, were analyzed for their abilities to support Streptococcus mutans biofilm formation and acid production, and their capacity to buffer changes in pH. Biofilm formation by S. mutans was analyzed using an in vitro 96-well plate model and measured by crystal violet staining. Acid production by S. mutans was evaluated by a colorimetric L-lactate assay and pH measurement of bacterial cultures. Buffering capacity was assessed by a pH titration assay. Soy milk supported the most biofilm growth, while the least was observed with unsweetened almond milk (both p < 0.001). Among almond milks, sucrose-sweetened milk led to the highest level of biofilm formation (p < 0.001), while the least was observed with unsweetened milk (p < 0.05). Sucrose-sweetened almond milk yielded the lowest pH (4.56 ± 0.66), followed by soy milk and bovine milk; the highest pH was with unsweetened almond milk (6.48 ± 0.5). When analyzed by pH titration, the unsweetened almond milk displayed the weakest buffering capacity while bovine milk showed the highest (p < 0.001). These results suggest that the almond milk beverages, except those that are sweetened with sucrose, possess limited cariogenic properties, while soy milk exhibits the most cariogenic potential. As milk alternatives become increasingly popular, dentists must counsel their patients that almond milks, especially sucrose-sweetened varieties, have cariogenic potential. For patients who are lactose-intolerant or suffer from milk allergy, almond milks may be a better alternative than soy-based products.

Keywords:
Almond milk, Cariogenicity, Dental caries, Streptococcus mutans
1.
Bergsson G, Arnfinnsson J, Steingrimsson O, Thormar H: In vitro killing of Candida albicans by fatty acids and monoglycerides. Antimicrob Agents Chemother 2001;45:3209-3212.
2.
Bitoun JP, Liao S, Yao X, Xie GG, Wen ZT: The redox-sensing regulator rex modulates central carbon metabolism, stress tolerance response and biofilm formation by Streptococcus mutans. PLoS One 2012;7:e44766.
3.
Bowen WH, Pearson SK, Rosalen PL, Miguel JC, Shih AY: Assessing the cariogenic potential of some infant formulas, milk and sugar solutions. J Am Dent Assoc 1997;128:865-871.
4.
Boyce JA, Assa'ad A, Burks AW, Jones SM, Sampson HA, Wood RA, et al; NIAID-Sponsored Expert Panel: Guidelines for the diagnosis and management of food allergy in the United States: summary of the NIAID-sponsored expert panel report. J Allergy Clin Immunol 2010;126:1105-1118.
5.
Burne RA: Oral streptococci... products of their environment. J Dent Res 1998;77:445-452.
6.
Dashper SG, Saion BN, Stacey MA, Manton DJ, Cochrane NJ, Stanton DP, Yuan Y, Reynolds EC: Acidogenic potential of soy and bovine milk beverages. J Dent 2012;40:736-741.
7.
Ellis D, Lieb J: Hyperoxaluria and genitourinary disorders in children ingesting almond milk products. J Pediatr 2015;167:1155-1158.
8.
Giacaman RA, Munoz-Sandoval C: Cariogenicity of different commercially available bovine milk types in a biofilm caries model. Pediatr Dent 2014;36:1E-6E.
9.
Gibson RS, Bailey KB, Gibbs M, Ferguson EL: A review of phytate, iron, zinc, and calcium concentrations in plant-based complementary foods used in low-income countries and implications for bioavailability. Food Nutr Bull 2010;31:S134-S146.
10.
Jefferson WN: Adult ovarian function can be affected by high levels of soy. J Nutr 2010;140:2322S-2325S.
11.
Kulis M, Wright BL, Jones SM, Burks AW: Diagnosis, management, and investigational therapies for food allergies. Gastroenterology 2015;148:1132-1142.
12.
Lieberman JA, Weiss C, Furlong TJ, Sicherer M, Sicherer SH: Bullying among pediatric patients with food allergy. Ann Allergy Asthma Immunol 2010;105:282-286.
13.
Loesche WJ: Role of Streptococcus mutans in human dental decay. Microbiol Rev 1986;50:353-380.
14.
Loo CY, Corliss DA, Ganeshkumar N: Streptococcus gordonii biofilm formation: identification of genes that code for biofilm phenotypes. J Bacteriol 2000;182:1374-1382.
15.
Mandalari G, Bisignano C, D'Arrigo M, Ginestra G, Arena A, Tomaino A, Wickham MS: Antimicrobial potential of polyphenols extracted from almond skins. Lett Appl Microbiol 2010a;51:83-89.
16.
Mandalari G, Faulks RM, Bisignano C, Waldron KW, Narbad A, Wickham MS: In vitro evaluation of the prebiotic properties of almond skins (Amygdalus communis l.). FEMS Microbiol Lett 2010b;304:116-122.
17.
Munoz-Sandoval C, Munoz-Cifuentes MJ, Giacaman RA, Ccahuana-Vasquez RA, Cury JA: Effect of bovine milk on Streptococcus mutans biofilm cariogenic properties and enamel and dentin demineralization. Pediatr Dent 2012;34:e197-e201.
18.
Patisaul HB, Jefferson W: The pros and cons of phytoestrogens. Front Neuroendocrinol 2010;31:400-419.
19.
Prabhakar AR, Kurthukoti AJ, Gupta P: Cariogenicity and acidogenicity of human milk, plain and sweetened bovine milk: an in vitro study. J Clin Pediatr Dent 2010;34:239-247.
20.
Sheik C, Erickson PR: Evaluation of plaque pH changes following oral rinse with eight infant formulas. Pediatr Dent 1996;18:200-2004.
21.
Tinanoff N, Reisine S: Update on early childhood caries since the Surgeon General's Report. Acad Pediatr 2009;9:396-403.
22.
Wang V: America's almond milk boom tops $700 million in sales. 2016a. http://www.Bloomberg.Com/news/articles/2014-08-08/the-almond-milk-boom-silks-huge-sales-lead-the-way-trounce-soys (archived by webcite@ at http://www.Webcitation.Org/6mlvwuvep) (accessed November 26, 2016).
23.
Wang V: Soy milk fades as Americans opt for drinkable almonds. 2016b. http://www.Bloomberg.Com/news/articles/2013-08-21/soy-milk-fades-as-americans-opt-for-drinkable-almonds (archived by webcite@ at http://www.Webcitation.Org/6mlxu3ve5) (accessed November 26, 2016).
24.
Wen ZT, Burne RA: Functional genomics approach to identifying genes required for biofilm development by Streptococcus mutans. Appl Environ Microbiol 2002;68:1196-1203.
25.
Yamada T, Takahashi-Abbe S, Abbe K: Effects of oxygen on pyruvate formate-lyase in situ and sugar metabolism of Streptococcus mutans and Streptococcus sanguis. Infect Immun 1985;47:129-134.
© 2017 S. Karger AG, Basel
2017
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.